Quantum-Si (NASDAQ:QSI) Research Coverage Started at Alliance Global Partners

Alliance Global Partners initiated coverage on shares of Quantum-Si (NASDAQ:QSI) in a report published on Friday, Marketbeat Ratings reports. The brokerage issued a buy rating and a $3.75 target price on the stock.

Other analysts also recently issued research reports about the stock. Canaccord Genuity Group cut their price objective on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a report on Wednesday, November 13th. HC Wainwright restated a “buy” rating and set a $5.50 price target on shares of Quantum-Si in a report on Tuesday, January 14th.

Quantum-Si Trading Up 7.4 %

QSI stock opened at $2.04 on Friday. The company has a market cap of $291.13 million, a price-to-earnings ratio of -3.19 and a beta of 2.69. Quantum-Si has a 12 month low of $0.61 and a 12 month high of $5.77. The firm has a 50-day moving average of $2.15 and a two-hundred day moving average of $1.36.

Insider Transactions at Quantum-Si

In related news, Director Jonathan M. Rothberg sold 3,506,267 shares of Quantum-Si stock in a transaction that occurred on Friday, December 27th. The shares were sold at an average price of $3.34, for a total value of $11,710,931.78. Following the completion of the sale, the director now owns 1,250,000 shares in the company, valued at approximately $4,175,000. This trade represents a 73.72 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 30.04% of the company’s stock.

Institutional Trading of Quantum-Si

Institutional investors have recently added to or reduced their stakes in the stock. Geode Capital Management LLC boosted its position in Quantum-Si by 6.7% in the 3rd quarter. Geode Capital Management LLC now owns 2,316,921 shares of the company’s stock valued at $2,044,000 after buying an additional 145,091 shares during the period. Charles Schwab Investment Management Inc. boosted its position in Quantum-Si by 32.6% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 308,021 shares of the company’s stock valued at $832,000 after buying an additional 75,661 shares during the period. Bank of New York Mellon Corp lifted its position in shares of Quantum-Si by 21.3% during the 4th quarter. Bank of New York Mellon Corp now owns 269,807 shares of the company’s stock worth $728,000 after purchasing an additional 47,400 shares during the last quarter. Barclays PLC lifted its position in shares of Quantum-Si by 210.5% during the 3rd quarter. Barclays PLC now owns 196,826 shares of the company’s stock worth $173,000 after purchasing an additional 133,438 shares during the last quarter. Finally, Rhumbline Advisers lifted its position in shares of Quantum-Si by 3.7% during the 4th quarter. Rhumbline Advisers now owns 148,946 shares of the company’s stock worth $402,000 after purchasing an additional 5,298 shares during the last quarter. Institutional investors and hedge funds own 39.90% of the company’s stock.

Quantum-Si Company Profile

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.